• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The second recurrence of complex lung disease after successful treatment for first recurrence.

作者信息

Kwon Byoung Soo, Shim Tae Sun, Jo Kyung-Wook

机构信息

Division of Pulmonology and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.

出版信息

Eur Respir J. 2019 Jan 3;53(1). doi: 10.1183/13993003.01038-2018. Print 2019 Jan.

DOI:10.1183/13993003.01038-2018
PMID:30337449
Abstract
摘要

相似文献

1
The second recurrence of complex lung disease after successful treatment for first recurrence.首次复发成功治疗后复杂性肺部疾病的第二次复发。
Eur Respir J. 2019 Jan 3;53(1). doi: 10.1183/13993003.01038-2018. Print 2019 Jan.
2
Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病成功治疗后复发的危险因素。
Antimicrob Agents Chemother. 2015;59(6):2972-7. doi: 10.1128/AAC.04577-14. Epub 2015 Mar 9.
3
Treatment Duration and Disease Recurrence Following the Successful Treatment of Patients With Mycobacterium avium Complex Lung Disease.鸟分枝杆菌复合群肺病患者成功治疗后的治疗持续时间和疾病复发情况。
Chest. 2020 Jun;157(6):1442-1445. doi: 10.1016/j.chest.2019.12.016. Epub 2020 Jan 16.
4
Treatment of pulmonary disease caused by Mycobacterium avium complex.鸟分枝杆菌复合体引起的肺部疾病的治疗。
Intern Med. 2003 Aug;42(8):627-8. doi: 10.2169/internalmedicine.42.627.
5
Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.反复分枝杆菌肺病的结节性支气管扩张症间断抗生素治疗。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.01812-17. Print 2018 Feb.
6
Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病成功治疗后复发的决定因素。
Int J Tuberc Lung Dis. 2015 Oct;19(10):1239-45. doi: 10.5588/ijtld.14.0139.
7
Rifampicin has no role in treatment of complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint.利福平在治疗复杂肺部疾病中没有作用，需要使用杀菌药物：一个观点。
Eur Respir J. 2024 May 2;63(5). doi: 10.1183/13993003.02210-2023. Print 2024 May.
8
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.鸟分枝杆菌复合群肺病治疗的临床疗效与鸟分枝杆菌复合群分离株药敏试验之间的关系
J Infect Chemother. 2006 Aug;12(4):195-202. doi: 10.1007/s10156-006-0457-8.
9
Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.大环内酯类耐药与难治性鸟分枝杆菌复合群肺病再感染的发生
Am J Respir Crit Care Med. 2018 Nov 15;198(10):1322-1330. doi: 10.1164/rccm.201802-0321OC.
10
Mycobacterium avium complex lung disease and panhypopituitarism.
Mayo Clin Proc. 2005 Jul;80(7):961-2. doi: 10.4065/80.7.961-a.

引用本文的文献

1
Treatment for non-tuberculous mycobacteria: challenges and prospects.非结核分枝杆菌的治疗：挑战与前景
Front Microbiol. 2024 Jun 3;15:1394220. doi: 10.3389/fmicb.2024.1394220. eCollection 2024.
2
Bigger problems from smaller colonies: emergence of antibiotic-tolerant small colony variants of Mycobacterium avium complex in MAC-pulmonary disease patients.更小的菌落带来更大的问题：耐抗生素的鸟分枝杆菌复合群小菌落变体在 MAC-肺病患者中的出现。
Ann Clin Microbiol Antimicrob. 2024 Mar 18;23(1):25. doi: 10.1186/s12941-024-00683-6.
3
A novel repeat sequence-based PCR (rep-PCR) using specific repeat sequences of as a DNA fingerprinting.
一种基于新型重复序列的聚合酶链反应（rep-PCR），使用[具体重复序列]作为DNA指纹识别技术。 （原文中“specific repeat sequences of ”这里表述不完整，缺少具体内容）
Front Microbiol. 2023 Apr 6;14:1161194. doi: 10.3389/fmicb.2023.1161194. eCollection 2023.
4
Outcome of shorter treatment duration in non-cavitary nodular bronchiectatic complex lung disease.非空洞性结节性支气管扩张复杂型肺病较短疗程的治疗结果
J Thorac Dis. 2020 Mar;12(3):338-348. doi: 10.21037/jtd.2020.01.39.
5
Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in Complex Lung Disease.因复杂肺部疾病的不良反应而停用乙胺丁醇后的治疗结果。
J Korean Med Sci. 2020 Mar 9;35(9):e59. doi: 10.3346/jkms.2020.35.e59.